Industry News

Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration...

Creative Biolabs has developed validated protocols to purify exosomes from both plasma and other body fluids, including ultracentrifugation, microfiltration, size exclusion chromatography, and immunoaffinity capture. As exosomes can transmit the information of donor cells to recipient cells through the proteins, ...

Izon Science Ltd, the world-leading manufacturer of nano-biological separation and characterisation tools, announced today the release of two new kits...

With abundant experience on exosome research over the past years, Creative Biolabs has updated exosome proteomics services covering phosphorylation proteomics, lable-free proteomics and labeling proteomics technologies. Exosomes, small lipid bilayer-enclosed particles of endosomal origin, are a subset of extracellular vesicles ...

ReNerve and VivaZome Therapeutics today announced that they have entered a collaboration to combine their leading scaffold and exosome technologies, skills and experience to explore new...

Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, a biotech company developing an innovative drug delivery platform based on...

EV-Chip paves way for new generation of portable, point-of-care devices. Enables real-time analysis of liquid biopsy samples for biomarkers of cancer, other...

Capricor Therapeutics, a biotechnology company focused on the development of transformative cell- and exosome-based therapeutics for the treatment...

Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced positive results for the first ten COVID-19...

Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration...